Skip to content
healthcare.dev

DAXXIFY

NDC 72960-112, botulinum toxin type A, injection, powder, lyophilized, for solution, from Revance Therapeutics, Inc..

Product NDC
72960-112
Status
Listed
Labeler
Revance Therapeutics, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761127
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72960-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BOTULINUM TOXIN TYPE A100 U/1.2mL

Pharmacologic classes

Acetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Neuromuscular Blockade [PE]; Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
72960-112-01729600112011 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE
72960-112-02729600112021 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72960-112

Use it

Look up 72960-112 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72960-112 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72960-112. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.